Veriheal

MARCH 1, 2022

The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapy program. Oregon’s Psilocybin Therapy Program: Advisory Board Hard at Work.

Therapy 98

Therapy Programs Microdosing Medicine 98

Cannabis Law Report

SEPTEMBER 10, 2021

is a pioneering Psychedelic Healthcare Innovation & Life Sciences Company in early stage development of Psilocybin (“Magic Mushroom”) based drugs and therapies proudly announces t he Filing of U. Patents Protecting Its Proprietary Psychedelic Therapeutic Process and Tele-Mental Health & Microdosing Platform.

Microdosing 98

Microdosing Research and Development Therapy Treatment 98

Veriheal

OCTOBER 20, 2021

Always consult a physician before attempting psychedelic therapy. According to Dr. Maria Rahmandar , medical director of the substance use program at Lurie Children’s Hospital of Chicago, “The findings here are pretty consistent with what I see clinically. Cannabis and magic mushrooms for the win! Talk about mixed signals.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

Cannabis Law Report

JULY 13, 2022

Optimi will supply Bloom with sufficient biomass of natural psilocybin to begin conducting its previously announced clinical trial in partnership with the IMPACT Clinical Trial Accelerator Program housed within Alberta’s Life Sciences Innovation Hub at the University of Calgary.

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

Cannabis Law Report

AUGUST 10, 2022

On July 14 , Optimi Health announced that it has finalized a supply agreement with Bloom Psychedelic Therapy And Research Center, a Calgary -based provider of mental health services, including psychedelic-assisted therapies using ketamine treatments.

Clinical Trials 52

Clinical Trials Research and Development Therapy Microdosing 52

Veriheal

MAY 13, 2022

Oregon steered the nation in 2020 when voters unanimously voted in support of a ballot measure— Oregon Measure 109, the Psilocybin Program Initiative —legalizing and providing regulatory oversight for the consumption of psilocybin-producing mushroom and fungi products for individuals aged 21 and above. milligrams.

Research and Development 98

Research and Development Legalization Consumption Microdosing 98

SpeedWeed

MAY 1, 2021

These products are often sold in packages of 100mg per edible for microdosing, or one gram per gummy for full-on psychedelic exploration. When these programs are finally implemented, you can bet that therapists will decide to give patients perfectly-dosed psilocybin edibles instead of forcing them to munch dried boomers.

Edibles 52

Edibles Microdosing Therapy Tincture 52